The expert assessed the prospect of increasing the production of veterinary drugs by 5 times

“The figures and challenges are absolutely real, especially if we look at the dynamics of development in certain segments of veterinary drugs. In a fairly short period of time, in certain market segments we have exceeded 50%, in some segments we are already close to 90%, in some segments we are still developing. If we talk about veterinary pharmaceuticals, then we and our colleagues in the shop have production facilities. Our company can increase its capacity by 3 times from the existing production volumes. A small modernization will allow increasing production volumes by 5 times,” Sergey Kasparyants assured.

Recall that recently the industry of production of veterinary drugs was singled out as a separate line of economic activity. The production of veterinary drugs and materials for veterinary use was assigned separate codes in the All-Russian Classifier of Economic Activities (OKVED). Sergey Kasparyants explained that this would allow producers to count on additional state support measures. For example, on soft loans. Such support will allow launching science-intensive complex production.

“We have three projects with a total capacity of about 5 billion rubles, which are aimed at the production of new innovative products for agriculture and small domestic animals. These projects will expand the range and reduce import dependence for our industry,” summed up the interlocutor of “ViZh”.